An interventional study of Integrated Fabric-Type Orthosis in Sarcopenia, Older Adults (65 Years and Older) and Gait Analysis, sponsored by Seoul National University Hospital. Recruiting at 1 site in South Korea. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 41 studies in Sarcopenia with a site in Korea, Republic of — 14 open to participants now, 16 under way, none of them phase 3. Sarcopenia · Korea, Republic of.
Among the 41 studies in Sarcopenia with a site in Korea, Republic of, this one is the 28th largest by planned enrollment of the 30 interventional ones that give a count, is one of 4 that started in 2026, is one of 20 with no phase, reaches primary completion later than 13 of the 15 other live ones, and was the 38th registered.
1,331 studies on the registry are indexed under Sarcopenia; 419 are open to participants now.
Browse Sarcopenia studies →14 of the 41 studies in Sarcopenia with a site in Korea, Republic of are open now. Recruiting first, the newest first:
Pusan National University Yangsan Hospital · Sites in Korea, Republic of
Ages 50–79 · Healthy volunteers
Pluto Inc. · Sites in Korea, Republic of
Ages 65+
Animuscure Inc. · Sites in Korea, Republic of
Ages 65+
Seoul National University Bundang Hospital · Sites in Korea, Republic of
Ages 20–90 · Healthy volunteers
Seoul National University Hospital · Sites in Korea, Republic of
Ages 40–100
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 247 Sarcopenia studies recruiting now, 154 (62%) set no upper age limit and 32 (13%) stop at 75 or younger; 9 take children under 18; 64 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
41 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 6 · Phase 4 3
First in 2009; this study’s year is marked. 4 started in 2026.
This study's planned enrollment of 30 is below the median of 60 across 857 interventional studies indexed under Sarcopenia.
Median enrollment 80 across the 30 interventional studies, 150 across the 11 observational. Of the 19 that completed or were terminated, 2 (11%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 41 have an industry lead sponsor. The 10 most frequent:
Seoul National University Hospital is the lead sponsor of 1,903 studies on the registry; 277 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Seoul National University Hospital has 8 studies filed under Sarcopenia — fewer than ten, so there is no comparison to draw.
3 of the studies in Sarcopenia with a site in Korea, Republic of that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07634523Seoul National University HospitalBranched Chain Amino Acids for Sarcopenia in Patients Undergoing Total Knee Arthroplasty | 2027-05-31 |
| NCT07749118Pusan National University Yangsan HospitalHB05P on Muscle Health | 2027-06-29 |
| NCT07390552Pluto Inc.A Study of PLH-2301 in Subjects With Sarcopenia | 2027-06-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 41 studies in Sarcopenia with a site in Korea, Republic of, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This pilot clinical trial aims to evaluate the safety and feasibility of an integrated fabric-type orthosis with muscle-mimicking and proprioception-enhancing functions in older adults with geriatric conditions affecting gait and balance. The wearable orthosis provides lower-limb assistance through a fabric-based actuation system and vibrotactile proprioceptive stimulation. Thirty participants aged 65 years or older will undergo gait, balance, proprioception, and electromyography assessments under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on. Outcome measures include gait performance, postural sway, one-leg standing balance, joint position sense, muscle activation, physiological responses, fatigue, and device-related adverse events. The study is designed as an exploratory pilot trial to assess the clinical applicability, usability, and safety of the wearable assistive device in geriatric patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Eligibility for participation in the study requires that all the following criteria are met:
Mobility-Impacting Conditions: Must have at least one of the following conditions affecting mobility: (1)Sarcopenia:
Exclusion Criteria:
Individuals meeting any of the following criteria will be excluded from study participation:
Other Significant Diseases or Conditions:
Other Exclusionary Factors:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will undergo gait, balance, proprioception, and electromyography assessments under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on. The wearable fabric-type orthosis provides muscle-mimicking lower-limb assistance and proprioception-enhancing vibrotactile stimulation for gait and balance support in older adults.
Device: Integrated Fabric-Type Orthosis
A wearable fabric-type lower-limb orthosis integrating muscle-mimicking actuation and proprioception-enhancing vibrotactile stimulation. The device is designed to assist knee and ankle movements during gait and balance activities in older adults with gait and balance impairments. Participants will be evaluated under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on.
Also known as: Soft Exosuit
Change in Blood Pressure From Before to After Functional Assessment
Systolic and Diastolic blood pressure will be measured in millimeters of mercury (mmHg) before and after completion of the functional assessment, which includes gait and balance tests performed under the designated orthosis conditions.
Time frame: Immediately before and after the functional assessment at each study visit
Change in Heart Rate From Before to After Functional Assessment
Heart rate will be measured in beats per minute (bpm) before and after completion of the functional assessment, which includes gait and balance tests performed under the designated orthosis conditions.
Time frame: Immediately before and after the functional assessment at each study visit
Change in Perceived Exertion From Before to After Functional Assessment
Perceived exertion will be assessed using the Borg Scale before and after completion of the functional assessment. Higher scores indicate greater perceived exertion.
Time frame: Immediately before and after the functional assessment at each study visit
Change in Pain Intensity From Before to After Functional Assessment
Pain intensity will be assessed using the Numeric Rating Scale (NRS) before and after completion of the functional assessment. Scores range from 0 to 10, with higher scores indicating greater pain intensity.
Time frame: Immediately before and after the functional assessment at each study visit
6-Minute Walk Test
To evaluate walking endurance and functional mobility by measuring the maximum walking distance achieved within six minutes.
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
10-Meter Walk Test
To assess gait speed and short-distance walking performance under different orthosis conditions.
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
20-Meter Walk Test
To assess walking speed and gait performance over a longer walking distance.
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Surface Electromyography
To evaluate lower-limb muscle activation patterns during walking using surface electromyography (sEMG).
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Static One-Leg Standing Balance Test
To evaluate static balance ability by measuring the duration participants can maintain single-leg standing.
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Postural Sway
To assess postural stability during quiet standing using center of pressure (COP)-based balance measurements.
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Passive Joint Position Reproduction Test
To evaluate proprioceptive accuracy by measuring passive knee joint position reproduction error.
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Active Joint Position Reproduction Test
To evaluate proprioceptive accuracy by measuring active knee joint position reproduction error.
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Participant Satisfaction
To assess participant satisfaction, comfort, perceived usability, and overall acceptance of the wearable orthosis.
Time frame: Immediately post-brace activation (power on)
Gait Speed
Gait speed measured using the GAITRite system, reported in meters per second (m/s).
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Cadence
Cadence measured using the GAITRite system, reported in steps per minute (steps/min).
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Step Time
Step time measured using the GAITRite system, reported in seconds (s).
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Step Length
Step length measured using the GAITRite system, reported in centimeters (cm).
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stride Time
Stride time measured using the GAITRite system, reported in seconds (s).
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stride Length
Stride length measured using the GAITRite system, reported in centimeters (cm).
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Single Support Time
Single support time measured using the GAITRite system, reported in seconds (s).
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Double Support Time
Double support time measured using the GAITRite system, reported in seconds (s).
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stance Time
Stance time measured using the GAITRite system, reported in seconds (s).
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Swing Time
Swing time measured using the GAITRite system, reported in seconds (s).
Time frame: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Plan to share: No
No publications or documents are linked to this record.
Started Jun 2026 (actual). Primary completion is estimated for Dec 2027, 18 months after the start.
Of 495 non-industry interventional studies with no phase under Sarcopenia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's planned 18 months is close to that.
Counting every sponsor, half of 506 studies reached it within 18 months; a quarter within 9 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital →